SHW vs TARS · P/E 29, rev $12.46B vs rev $336.0M
Sherwin-Williams Co (SHW) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
SHW currently screens at market cap $75.30B and trailing P/E 29.3. TARS currently screens at market cap $2.66B.
Not investment advice. Open the SHW and TARS stock pages for the full models.
Not investment advice.